Charlotte Berlin

Charlotte Berlin currently serves as the Global Marketing Lead at UCB, where responsibilities include leading the commercialization strategy for Hidradentitis Suppurativa. Concurrently, Charlotte is a Principal at Studio Volta, focusing on global professional and patient brand strategy consulting. Prior experience includes a role as Director of Immunology at AbbVie, overseeing early commercial strategy for pipeline assets, and a Sr. Director position at Astellas Pharma, where Charlotte managed global marketing strategy for immunology and related therapeutic areas. Notably, during earlier tenure at Astellas, Charlotte successfully directed the US Immunology division, achieving significant revenue milestones for the Prograf product.